Global Biopharmaceuticals Market 2020 by Company, Regions, Type and Application, Forecast to 2025
Summary
Market Overview
The global Biopharmaceuticals market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.5% in the forecast period of 2020 to 2025 and will expected to reach USD 96040 million by 2025, from USD 80660 million in 2019.
The Biopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Biopharmaceuticals market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Biopharmaceuticals market has been segmented into Monoclonal Antibodies, Interferon, Colony-Stimulating Factor, Erythropoietin, Insulin, Vaccines, Growth Hormones, Others, etc.
By Application, Biopharmaceuticals has been segmented into Tumor, Diabetes, Cardiovascular, Hemophilia, Others, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biopharmaceuticals market presented in the report. This section sheds light on the sales growth of different regional and country-level Biopharmaceuticals markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biopharmaceuticals market.
The report offers in-depth assessment of the growth and other aspects of the Biopharmaceuticals market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Biopharmaceuticals markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Biopharmaceuticals Market Share Analysis
Biopharmaceuticals competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Biopharmaceuticals sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biopharmaceuticals sales, revenue and market share for each player covered in this report.
The major players covered in Biopharmaceuticals are: Roche, Eli Lilly, Sanofi-Aventis, Amgen, Novo Nordisk, AbbVie, Merck, Pfizer, Johnson & Johnson, Novartis, etc. Among other players domestic and global, Biopharmaceuticals market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Table of Contents
1 Biopharmaceuticals Market Overview
1.1 Product Overview and Scope of Biopharmaceuticals
1.2 Classification of Biopharmaceuticals by Type
1.2.1 Global Biopharmaceuticals Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Biopharmaceuticals Revenue Market Share by Type in 2019
1.2.3 Monoclonal Antibodies
1.2.4 Interferon
1.2.5 Colony-Stimulating Factor
1.2.6 Erythropoietin
1.2.7 Insulin
1.2.8 Vaccines
1.2.9 Growth Hormones
1.2.10 Others
1.3 Global Biopharmaceuticals Market by Application
1.3.1 Overview: Global Biopharmaceuticals Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Others
1.4 Global Biopharmaceuticals Market by Regions
1.4.1 Global Biopharmaceuticals Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Biopharmaceuticals (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Biopharmaceuticals Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Biopharmaceuticals Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biopharmaceuticals Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Biopharmaceuticals Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biopharmaceuticals Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Biopharmaceuticals Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Eli Lilly SWOT Analysis
2.2.4 Eli Lilly Product and Services
2.2.5 Eli Lilly Biopharmaceuticals Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi-Aventis
2.3.1 Sanofi-Aventis Details
2.3.2 Sanofi-Aventis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi-Aventis SWOT Analysis
2.3.4 Sanofi-Aventis Product and Services
2.3.5 Sanofi-Aventis Biopharmaceuticals Revenue, Gross Margin and Market Share (2018-2019)
2.4 Amgen
2.4.1 Amgen Details
2.4.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Amgen SWOT Analysis
2.4.4 Amgen Product and Services
2.4.5 Amgen Biopharmaceuticals Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novo Nordisk
2.5.1 Novo Nordisk Details
2.5.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novo Nordisk SWOT Analysis
2.5.4 Novo Nordisk Product and Services
2.5.5 Novo Nordisk Biopharmaceuticals Revenue, Gross Margin and Market Share (2018-2019)
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AbbVie SWOT Analysis
2.6.4 AbbVie Product and Services
2.6.5 AbbVie Biopharmaceuticals Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck SWOT Analysis
2.7.4 Merck Product and Services
2.7.5 Merck Biopharmaceuticals Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Pfizer SWOT Analysis
2.8.4 Pfizer Product and Services
2.8.5 Pfizer Biopharmaceuticals Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Johnson & Johnson SWOT Analysis
2.9.4 Johnson & Johnson Product and Services
2.9.5 Johnson & Johnson Biopharmaceuticals Revenue, Gross Margin and Market Share (2018-2019)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Novartis SWOT Analysis
2.10.4 Novartis Product and Services
2.10.5 Novartis Biopharmaceuticals Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Biopharmaceuticals Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Biopharmaceuticals Players Market Share
3.2.2 Top 10 Biopharmaceuticals Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Biopharmaceuticals Revenue and Market Share by Regions
4.2 North America Biopharmaceuticals Revenue and Growth Rate (2015-2020)
4.3 Europe Biopharmaceuticals Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Biopharmaceuticals Revenue and Growth Rate (2015-2020)
4.5 South America Biopharmaceuticals Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Biopharmaceuticals Revenue and Growth Rate (2015-2020)
5 North America Biopharmaceuticals Revenue by Countries
5.1 North America Biopharmaceuticals Revenue by Countries (2015-2020)
5.2 USA Biopharmaceuticals Revenue and Growth Rate (2015-2020)
5.3 Canada Biopharmaceuticals Revenue and Growth Rate (2015-2020)
5.4 Mexico Biopharmaceuticals Revenue and Growth Rate (2015-2020)
6 Europe Biopharmaceuticals Revenue by Countries
6.1 Europe Biopharmaceuticals Revenue by Countries (2015-2020)
6.2 Germany Biopharmaceuticals Revenue and Growth Rate (2015-2020)
6.3 UK Biopharmaceuticals Revenue and Growth Rate (2015-2020)
6.4 France Biopharmaceuticals Revenue and Growth Rate (2015-2020)
6.5 Russia Biopharmaceuticals Revenue and Growth Rate (2015-2020)
6.6 Italy Biopharmaceuticals Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Biopharmaceuticals Revenue by Countries
7.1 Asia-Pacific Biopharmaceuticals Revenue by Countries (2015-2020)
7.2 China Biopharmaceuticals Revenue and Growth Rate (2015-2020)
7.3 Japan Biopharmaceuticals Revenue and Growth Rate (2015-2020)
7.4 Korea Biopharmaceuticals Revenue and Growth Rate (2015-2020)
7.5 India Biopharmaceuticals Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Biopharmaceuticals Revenue and Growth Rate (2015-2020)
8 South America Biopharmaceuticals Revenue by Countries
8.1 South America Biopharmaceuticals Revenue by Countries (2015-2020)
8.2 Brazil Biopharmaceuticals Revenue and Growth Rate (2015-2020)
8.3 Argentina Biopharmaceuticals Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Biopharmaceuticals by Countries
9.1 Middle East & Africa Biopharmaceuticals Revenue by Countries (2015-2020)
9.2 Saudi Arabia Biopharmaceuticals Revenue and Growth Rate (2015-2020)
9.3 UAE Biopharmaceuticals Revenue and Growth Rate (2015-2020)
9.4 Egypt Biopharmaceuticals Revenue and Growth Rate (2015-2020)
9.5 South Africa Biopharmaceuticals Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Biopharmaceuticals Revenue and Market Share by Type (2015-2020)
10.2 Global Biopharmaceuticals Market Forecast by Type (2019-2024)
10.3 Monoclonal Antibodies Revenue Growth Rate (2015-2025)
10.4 Interferon Revenue Growth Rate (2015-2025)
10.5 Colony-Stimulating Factor Revenue Growth Rate (2015-2025)
10.6 Erythropoietin Revenue Growth Rate (2015-2025)
10.7 Insulin Revenue Growth Rate (2015-2025)
10.8 Vaccines Revenue Growth Rate (2015-2025)
10.9 Growth Hormones Revenue Growth Rate (2015-2025)
10.10 Others Revenue Growth Rate (2015-2025)
11 Global Biopharmaceuticals Market Segment by Application
11.1 Global Biopharmaceuticals Revenue Market Share by Application (2015-2020)
11.2 Biopharmaceuticals Market Forecast by Application (2019-2024)
11.3 Tumor Revenue Growth (2015-2020)
11.4 Diabetes Revenue Growth (2015-2020)
11.5 Cardiovascular Revenue Growth (2015-2020)
11.6 Hemophilia Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Biopharmaceuticals Market Size Forecast (2021-2025)
12.1 Global Biopharmaceuticals Market Size Forecast (2021-2025)
12.2 Global Biopharmaceuticals Market Forecast by Regions (2021-2025)
12.3 North America Biopharmaceuticals Revenue Market Forecast (2021-2025)
12.4 Europe Biopharmaceuticals Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Biopharmaceuticals Revenue Market Forecast (2021-2025)
12.6 South America Biopharmaceuticals Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Biopharmaceuticals Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Biopharmaceuticals Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Biopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Biopharmaceuticals Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Biopharmaceuticals Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Roche Corporate Information, Location and Competitors
Table 6. Roche Biopharmaceuticals Major Business
Table 7. Roche Biopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 8. Roche SWOT Analysis
Table 9. Roche Biopharmaceuticals Product and Solutions
Table 10. Roche Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Eli Lilly Corporate Information, Location and Competitors
Table 12. Eli Lilly Biopharmaceuticals Major Business
Table 13. Eli Lilly Biopharmaceuticals Total Revenue (USD Million) (2018-2019)
Table 14. Eli Lilly SWOT Analysis
Table 15. Eli Lilly Biopharmaceuticals Product and Solutions
Table 16. Eli Lilly Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Sanofi-Aventis Corporate Information, Location and Competitors
Table 18. Sanofi-Aventis Biopharmaceuticals Major Business
Table 19. Sanofi-Aventis Biopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 20. Sanofi-Aventis SWOT Analysis
Table 21. Sanofi-Aventis Biopharmaceuticals Product and Solutions
Table 22. Sanofi-Aventis Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Amgen Corporate Information, Location and Competitors
Table 24. Amgen Biopharmaceuticals Major Business
Table 25. Amgen Biopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 26. Amgen SWOT Analysis
Table 27. Amgen Biopharmaceuticals Product and Solutions
Table 28. Amgen Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Novo Nordisk Corporate Information, Location and Competitors
Table 30. Novo Nordisk Biopharmaceuticals Major Business
Table 31. Novo Nordisk Biopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 32. Novo Nordisk SWOT Analysis
Table 33. Novo Nordisk Biopharmaceuticals Product and Solutions
Table 34. Novo Nordisk Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. AbbVie Corporate Information, Location and Competitors
Table 36. AbbVie Biopharmaceuticals Major Business
Table 37. AbbVie Biopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 38. AbbVie SWOT Analysis
Table 39. AbbVie Biopharmaceuticals Product and Solutions
Table 40. AbbVie Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Merck Corporate Information, Location and Competitors
Table 42. Merck Biopharmaceuticals Major Business
Table 43. Merck Biopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 44. Merck SWOT Analysis
Table 45. Merck Biopharmaceuticals Product and Solutions
Table 46. Merck Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Pfizer Corporate Information, Location and Competitors
Table 48. Pfizer Biopharmaceuticals Major Business
Table 49. Pfizer Biopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 50. Pfizer SWOT Analysis
Table 51. Pfizer Biopharmaceuticals Product and Solutions
Table 52. Pfizer Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Johnson & Johnson Corporate Information, Location and Competitors
Table 54. Johnson & Johnson Biopharmaceuticals Major Business
Table 55. Johnson & Johnson Biopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 56. Johnson & Johnson SWOT Analysis
Table 57. Johnson & Johnson Biopharmaceuticals Product and Solutions
Table 58. Johnson & Johnson Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Novartis Corporate Information, Location and Competitors
Table 60. Novartis Biopharmaceuticals Major Business
Table 61. Novartis Biopharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 62. Novartis SWOT Analysis
Table 63. Novartis Biopharmaceuticals Product and Solutions
Table 64. Novartis Biopharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Biopharmaceuticals Revenue (Million USD) by Players (2015-2020)
Table 66. Global Biopharmaceuticals Revenue Share by Players (2015-2020)
Table 67. Global Biopharmaceuticals Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Biopharmaceuticals Revenue Market Share by Regions (2015-2020)
Table 69. North America Biopharmaceuticals Revenue by Countries (2015-2020)
Table 70. North America Biopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 71. Europe Biopharmaceuticals Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Biopharmaceuticals Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Biopharmaceuticals Revenue by Countries (2015-2020)
Table 74. South America Biopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Biopharmaceuticals Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Biopharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 77. Global Biopharmaceuticals Revenue (Million USD) by Type (2015-2020)
Table 78. Global Biopharmaceuticals Revenue Share by Type (2015-2020)
Table 79. Global Biopharmaceuticals Revenue Forecast by Type (2021-2025)
Table 80. Global Biopharmaceuticals Revenue by Application (2015-2020)
Table 81. Global Biopharmaceuticals Revenue Share by Application (2015-2020)
Table 82. Global Biopharmaceuticals Revenue Forecast by Application (2021-2025)
Table 83. Global Biopharmaceuticals Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Biopharmaceuticals Picture
Figure 2. Global Biopharmaceuticals Revenue Market Share by Type in 2019
Figure 3. Monoclonal Antibodies Picture
Figure 4. Interferon Picture
Figure 5. Colony-Stimulating Factor Picture
Figure 6. Erythropoietin Picture
Figure 7. Insulin Picture
Figure 8. Vaccines Picture
Figure 9. Growth Hormones Picture
Figure 10. Others Picture
Figure 11. Biopharmaceuticals Revenue Market Share by Application in 2019
Figure 12. Tumor Picture
Figure 13. Diabetes Picture
Figure 14. Cardiovascular Picture
Figure 15. Hemophilia Picture
Figure 16. Others Picture
Figure 17. Global Biopharmaceuticals Revenue (USD Million) and Growth Rate (2015-2025)
Figure 18. North America Biopharmaceuticals Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Europe Biopharmaceuticals Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Asia-Pacific Biopharmaceuticals Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. South America Biopharmaceuticals Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Middle East and Africa Biopharmaceuticals Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Biopharmaceuticals Revenue (Million USD) and Growth Rate (2015-2025)
Figure 24. Global Biopharmaceuticals Revenue Share by Players in 2019
Figure 25. Global Top 5 Players Biopharmaceuticals Revenue Market Share in 2019
Figure 26. Global Top 10 Players Biopharmaceuticals Revenue Market Share in 2019
Figure 27. Key Players Market Share Trend
Figure 28. Global Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 29. Global Biopharmaceuticals Revenue Market Share by Regions (2015-2020)
Figure 30. Global Biopharmaceuticals Revenue Market Share by Regions in 2018
Figure 31. North America Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 32. Europe Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 33. Asia-Pacific Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 34. South America Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 35. Middle East and Africa Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 36. North America Biopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure 37. North America Biopharmaceuticals Revenue Market Share by Countries in 2019
Figure 38. USA Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 39. Canada Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 40. Mexico Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 41. Europe Biopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure 42. Europe Biopharmaceuticals Revenue Market Share by Countries in 2019
Figure 43. Germany Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 44. UK Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 45. France Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 46. Russia Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 47. Italy Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 48. Asia-Pacific Biopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure 49. Asia-Pacific Biopharmaceuticals Revenue Market Share by Countries in 2019
Figure 50. China Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 51. Japan Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 52. Korea Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 53. India Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 54. Southeast Asia Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 55. South America Biopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure 56. South America Biopharmaceuticals Revenue Market Share by Countries in 2019
Figure 57. Brazil Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 58. Argentina Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 59. Middle East and Africa Biopharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure 60. Middle East and Africa Biopharmaceuticals Revenue Market Share by Countries in 2019
Figure 61. Saudi Arabia Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 62. UAE Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 63. Egypt Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 64. South Africa Biopharmaceuticals Revenue and Growth Rate (2015-2020)
Figure 65. Global Biopharmaceuticals Revenue Share by Type (2015-2020)
Figure 66. Global Biopharmaceuticals Revenue Share by Type in 2019
Figure 67. Global Biopharmaceuticals Market Share Forecast by Type (2021-2025)
Figure 68. Global Monoclonal Antibodies Revenue Growth Rate (2015-2020)
Figure 69. Global Interferon Revenue Growth Rate (2015-2020)
Figure 70. Global Colony-Stimulating Factor Revenue Growth Rate (2015-2020)
Figure 71. Global Erythropoietin Revenue Growth Rate (2015-2020)
Figure 72. Global Insulin Revenue Growth Rate (2015-2020)
Figure 73. Global Vaccines Revenue Growth Rate (2015-2020)
Figure 74. Global Growth Hormones Revenue Growth Rate (2015-2020)
Figure 75. Global Others Revenue Growth Rate (2015-2020)
Figure 76. Global Biopharmaceuticals Revenue Share by Application (2015-2020)
Figure 77. Global Biopharmaceuticals Revenue Share by Application in 2019
Figure 78. Global Biopharmaceuticals Market Share Forecast by Application (2021-2025)
Figure 79. Global Tumor Revenue Growth Rate (2015-2020)
Figure 80. Global Diabetes Revenue Growth Rate (2015-2020)
Figure 81. Global Cardiovascular Revenue Growth Rate (2015-2020)
Figure 82. Global Hemophilia Revenue Growth Rate (2015-2020)
Figure 83. Global Others Revenue Growth Rate (2015-2020)
Figure 84. Global Biopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 85. Global Biopharmaceuticals Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 86. Global Biopharmaceuticals Revenue Market Share Forecast by Regions (2021-2025)
Figure 87. North America Biopharmaceuticals Revenue Market Forecast (2021-2025)
Figure 88. Europe Biopharmaceuticals Revenue Market Forecast (2021-2025)
Figure 89. Asia-Pacific Biopharmaceuticals Revenue Market Forecast (2021-2025)
Figure 90. South America Biopharmaceuticals Revenue Market Forecast (2021-2025)
Figure 91. Middle East and Africa Biopharmaceuticals Revenue Market Forecast (2021-2025)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets